Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Prevalence and Duration of Loss of Smell and Taste in  COVID-19 Patients

View through CrossRef
Background: The COVID-19 (Corona virus disease 2019) outbreak due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is an infectious disease intimidating the world. The COVID-19 common symptoms include cough, fever, malaise, dyspnea, myalgia and gastrointestinal disturbances. The loss of smell and taste has also been reported among patients with COVID-19. Objective: The objective of the study is to assess the prevalence and duration of loss of smell and taste among COVID-19 patients. Material and Methods: It was a cross-sectional study in which 150 COVID-19 patients were included. The enrolled patients answered a questionnaire at 14th (or more) days after confirmed infection. The patients’ responses were received online on data form and entered into computer software SPSS version 22.0. Frequencies and percentages were calculated and data was presented in tables and figures. Results: Out of 150 patients, 48.0% were 20-30 years old and 56.0% were male. Majority (82.0%) of patients experienced loss of smell and taste during COVID-19. 57.0% patients had lost smell and taste sense completely. 52.0% patients experienced smell and taste issues after other symptoms of COVID-19. Among 43.9% patients, the duration of these issues was more than 10 days. There were 30.1% patients who used any medicine or local remedy for COVID-19 treatment. Conclusion: Study concluded that loss of smell and taste was prevalent among patients with COVID-19 while duration was more than 10 days for most of the patients.   
Title: Prevalence and Duration of Loss of Smell and Taste in  COVID-19 Patients
Description:
Background: The COVID-19 (Corona virus disease 2019) outbreak due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is an infectious disease intimidating the world.
The COVID-19 common symptoms include cough, fever, malaise, dyspnea, myalgia and gastrointestinal disturbances.
The loss of smell and taste has also been reported among patients with COVID-19.
Objective: The objective of the study is to assess the prevalence and duration of loss of smell and taste among COVID-19 patients.
Material and Methods: It was a cross-sectional study in which 150 COVID-19 patients were included.
The enrolled patients answered a questionnaire at 14th (or more) days after confirmed infection.
The patients’ responses were received online on data form and entered into computer software SPSS version 22.
Frequencies and percentages were calculated and data was presented in tables and figures.
Results: Out of 150 patients, 48.
0% were 20-30 years old and 56.
0% were male.
Majority (82.
0%) of patients experienced loss of smell and taste during COVID-19.
57.
0% patients had lost smell and taste sense completely.
52.
0% patients experienced smell and taste issues after other symptoms of COVID-19.
Among 43.
9% patients, the duration of these issues was more than 10 days.
There were 30.
1% patients who used any medicine or local remedy for COVID-19 treatment.
Conclusion: Study concluded that loss of smell and taste was prevalent among patients with COVID-19 while duration was more than 10 days for most of the patients.
   .

Related Results

Exploring Smell Loss Patterns and Recovery Factors Among Covid-19 Patients in Benghazi, Libya
Exploring Smell Loss Patterns and Recovery Factors Among Covid-19 Patients in Benghazi, Libya
Objective: The main objective of this research is to investigate the recovery patterns and the demographic factors that affect patients with loss of smell post-COVID-19 disease in ...
What Are the Sensory Attributes Associated with Consumer Acceptance of Yellow Oyster Mushrooms (Pleurotus citrinopileatus)?
What Are the Sensory Attributes Associated with Consumer Acceptance of Yellow Oyster Mushrooms (Pleurotus citrinopileatus)?
The oyster mushroom is cultivated globally, renowned for its unique texture and umami flavor, as well as its rich content of nutrients and functional ingredients. This study aims t...
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract Introduction Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Predictors of Taste Dysfunction and Its Severity Among Patients With Chronic Kidney Disease
Predictors of Taste Dysfunction and Its Severity Among Patients With Chronic Kidney Disease
Background: Patients with chronic kidney disease (CKD) often complain of taste dysfunction. The prevalent taste dysfunction among patients with CKD predisposes them to malnutrition...
Pulmonary and Extra-Pulmonary Persistent COVID-19 sequalae
Pulmonary and Extra-Pulmonary Persistent COVID-19 sequalae
Abstract Background This study aimed to assess the prevalence of the pulmonary and extrapulmonary symptoms and complications ext...
Long COVID Treatment No Silver Bullets, Only a Few Bronze BBs
Long COVID Treatment No Silver Bullets, Only a Few Bronze BBs
Long COVID is the consequence of having had COVID. Long COVID has many other names including Long-haul COVID, Post-COVID conditions (PCC), Post-COVID-19 syndrome, Post-acute seque...
Long COVID Treatment No Silver Bullets, Only a Few Bronze BBs
Long COVID Treatment No Silver Bullets, Only a Few Bronze BBs
Long COVID is the consequence of having had COVID. Long COVID has many other names including Long-haul COVID, Post-COVID conditions (PCC), Post-COVID-19 syndrome, Post-acute seque...
Adakah Hubungan antara Usia dan Gangguan Indera Perasa pada Pasien COVID-19?
Adakah Hubungan antara Usia dan Gangguan Indera Perasa pada Pasien COVID-19?
Abstract—COVID-19 (coronavirus disease 2019) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical symptoms of COVID-19 pati...

Back to Top